Search Results
Sep 09, 2026, 07:49 ET The University of Chicago Launches Trott Center for Excellence in Rural America
another $100 million from other donors, bringing total planned support for the initiative to $300 million. Byron Trott, chairman and co-CEO of BDT & MSD Partners, earned both his undergraduate and MBA degrees from the University of Chicago."There is extraordinary undiscovered talent in rural America.
More news about: The University of Chicago
Sep 03, 2026, 15:39 ET AAHRPP, 5개 연구 기관 추가 인증
메드스타 헬스 연구소(MedStar Health Research Institute), 메릴랜드주 컬럼비아MSD 연구소(MSD Research Laboratories) 글로벌 임상개발(Global Clinical Development)한국MSD(MSD Korea Co., Ltd.) 글로벌 임상시험 운영(Global Clinical Trial Operations)트라이헬스(TriHealth
More news about: Association for the Accreditation of Human Research Protection Programs
Aug 31, 2026, 09:00 ET Forward Opens Free 30-Day Access to Its Award-Winning Network Digital Twin
customer experiences $14.2M in annual benefits through improved efficiency and security.Backed by A. Capital, Andreessen Horowitz, Goldman Sachs, MSD Partners, Omega Venture Partners, Section 32, and Threshold Ventures, Forward is headquartered in Santa Clara, California. For more information, visit
More news about: Forward Networks, Inc.
Aug 31, 2026, 09:00 ET Forward Opens Free 30-Day Access to Its Award-Winning Network Digital Twin
customer experiences $14.2M in annual benefits through improved efficiency and security.Backed by A. Capital, Andreessen Horowitz, Goldman Sachs, MSD Partners, Omega Venture Partners, Section 32, and Threshold Ventures, Forward is headquartered in Santa Clara, California. For more information, visit
More news about: Forward Networks, Inc.
Aug 20, 2026, 07:00 ET CHARTER AND COX COMMUNICATIONS COMPLETE TRANSACTION BENEFITING CUSTOMERS, LOCAL COMMUNITIES, EMPLOYEES AND SHAREHOLDERS
Wachtell, Lipton, Rosen & Katz served as legal counsel to Charter. Allen & Company served as financial advisor to Cox Enterprises. BDT & MSD Partners, Evercore and Wells Fargo served as financial advisors to Cox. Latham & Watkins LLP served as legal advisor to Cox Enterprises.In
More news about: Charter Communications, Inc.
Aug 18, 2026, 09:00 ET The Galien Foundation Announces 2026 International Prix Galien Award Nominees
MSDKEYTRUDAMSD Italia
More news about: The Galien Foundation
Aug 18, 2026, 03:04 ET WuXi Biologics Recognized for Industry Top Sustainable Biopharma Practices Empowering the Industry's Transformation Through Green CRDMO
commitments, value-chain decarbonization, green manufacturing, and sustainable operations. The list brings together global pharmaceutical leaders – such as MSD (Merck & Co.), Eli Lilly, Johnson & Johnson, AstraZeneca, Takeda, GSK and Bayer – collectively illustrating the diverse pathways through which
More news about: WuXi Biologics
Aug 17, 2026, 07:18 ET Kelun-Biotech Announces 2026 Interim Results
progressCollaboration with Merck Sharp & Dohme (hereinafter referred to as the "MSD") (默沙东): MSD has initiated 17 ongoing Phase 3 global clinical studies of sac-TMT as a monotherapy or in combination with pembrolizumab or other agents for
More news about: Kelun-biotech
Aug 14, 2026, 10:00 ET Phanes Therapeutics Receives FDA Fast Track Designation for Spevatamig in Advanced and Metastatic Biliary Tract Carcinoma
metastatic claudin 18.2-positive pancreatic adenocarcinoma in 2024. In 2023, Phanes entered into a clinical collaboration agreement with Merck (known as MSD outside the US and Canada) to study spevatamig in combination with pembrolizumab.Phanes is conducting clinical trials with spevatamig in multiple
More news about: Phanes Therapeutics, Inc.
Aug 12, 2026, 09:00 ET Oryx Dental Software Named to the 2026 Inc. 5000 List for the Third Consecutive Year
technology."Dentistry is at an inflection point. The future belongs to practices embracing modern, AI-powered technology," said Rania Saleh, DDS, MSD, Founder and CEO of Oryx. "Oryx's mission has always been to give clinicians the tools they need to provide exceptional patient care while building thriving
More news about: Oryx Dental
Aug 12, 2026, 07:00 ET Leap Therapeutics Announces Publication of DeFianCe Study Results in Clinical Cancer Research
range.Levels were concordant across two orthogonal platforms — an aptamer-based SomaScan assay and an antibody-based Meso Scale Discovery (MSD) assay (Spearman r=0.77).Tumoral DKK1 mRNA expression was low in most tissue samples, reinforcing that plasma — not tissue — reflects the systemic
More news about: Cypherpunk Technologies Inc.
Aug 11, 2026, 09:00 ET Grain Management Completes Acquisition of Nationwide 800 MHz Spectrum Portfolio
acquisition.Milbank LLP served as legal counsel to Grain, and Hogan Lovells Cadwalader served as regulatory counsel to Grain.BDT & MSD and Black & Veatch serve as strategic advisors to Grain.About Grain ManagementFounded in 2007, Grain Management is a leading
More news about: Grain Management, LLC
Aug 04, 2026, 06:00 ET Waters Corporation (NYSE: WAT) Reports Second Quarter 2026 Financial Results
reported revenue of $72 million in the quarter, compared to $62 million for the second quarter of 2025.Materials Sciences Division (MSD)The Materials Sciences Division – formerly known as TA Division – delivered reported revenue of $87 million in the quarter, compared to $82
More news about: Waters Corporation
Aug 04, 2026, 06:00 ET Waters Corporation (NYSE: WAT) Reports Second Quarter 2026 Financial Results
reported revenue of $72 million in the quarter, compared to $62 million for the second quarter of 2025.Materials Sciences Division (MSD)The Materials Sciences Division – formerly known as TA Division – delivered reported revenue of $87 million in the quarter, compared to $82
More news about: Waters Corporation
Jul 30, 2026, 05:09 ET NMPA Accepts New Indication Application for Sacituzumab Tirumotecan (sac-TMT) as First-Line Treatment for Advanced TNBC
registrational clinical studies in China. MSD has initiated 17 ongoing global Phase III clinical studies of sac-TMT as a monotherapy or in combination with pembrolizumab or other anti-cancer agents for several types of cancer. These studies are sponsored and led by MSD.About Kelun-BiotechKelun-Biotech
More news about: Kelun-Biotech
Jul 29, 2026, 12:27 ET Providence Equity Partners annonce un nouvel investissement dans THE•TEAM pour financer l'acquisition des parts détenues par le fondateur
Ellis LLP assure le conseil juridique de Providence.Moelis & Company LLC fait office de conseiller financier exclusif de THE•TEAM. BDT & MSD Partners fait office de conseiller financier de Casey Wasserman. Sullivan & Cromwell LLP assure le conseil juridique de Casey Wasserman et de THE•TEAM.À
More news about: Providence Equity Partners L.L.C.
Jul 29, 2026, 11:59 ET Providence Equity Partners gibt eine weitere Investition in THE•TEAM bekannt, um den Erwerb der Anteile des Gründers zu unterstützen
& Ellis LLP fungiert als Rechtsberater von Providence.Moelis & Company LLC fungiert als exklusiver Finanzberater für THE•TEAM. BDT & MSD Partners fungiert als Finanzberater von Casey Wasserman. Sullivan & Cromwell LLP fungiert als Rechtsberater von Casey Wasserman und THE•TEAM.Informationen
More news about: Providence Equity Partners L.L.C.
Jul 29, 2026, 09:29 ET Providence Equity Partners anuncia una inversión adicional en THE•TEAM
LLP actúa como asesor legal de Providence.Moelis & Company LLC actúa como asesor financiero exclusivo de THE•TEAM. BDT & MSD Partners actúa como asesor financiero de Casey Wasserman. Sullivan & Cromwell LLP actúa como asesor legal de Casey Wasserman y THE•TEAM.Acerca
More news about: Providence Equity Partners L.L.C.
Jul 29, 2026, 08:00 ET Bacterial Vaginosis: Merck Manuals Shares What Women and Partners Need to Know
MerckManuals.com.About The Merck Manuals and MSD ManualsFirst published in 1899 as a pocket-sized reference for physicians and pharmacists, The Merck Manual has evolved into one of the world's
More news about: The Merck Manuals
Jul 28, 2026, 19:16 ET Providence Equity Partners anuncia una inversión adicional en THE•TEAM para apoyar la adquisición de la participación accionaria del fundador
& Ellis LLP actúa como asesor jurídico de Providence.Moelis & Company LLC actúa como asesor financiero exclusivo de THE•TEAM. BDT & MSD Partners actúa como asesor financiero de Casey Wasserman. Sullivan & Cromwell LLP actúa como asesor jurídico de Casey Wasserman y THE•TEAM.Acerca
More news about: Providence Equity Partners L.L.C.
Jul 28, 2026, 19:00 ET Providence Equity Partners Announces Additional Investment in THE•TEAM to Support Acquisition of Founder's Ownership Interest
Ellis LLP is serving as Providence's legal counsel.Moelis & Company LLC is serving as exclusive financial advisor to THE•TEAM. BDT & MSD Partners is serving as financial advisor to Casey Wasserman. Sullivan & Cromwell LLP is serving as legal counsel to Casey Wasserman and THE•TEAM.About
More news about: Providence Equity Partners L.L.C.
Jul 28, 2026, 19:00 ET Providence Equity Partners Announces Additional Investment in THE•TEAM to Support Acquisition of Founder's Ownership Interest
Ellis LLP is serving as Providence's legal counsel.Moelis & Company LLC is serving as exclusive financial advisor to THE•TEAM. BDT & MSD Partners is serving as financial advisor to Casey Wasserman. Sullivan & Cromwell LLP is serving as legal counsel to Casey Wasserman and THE•TEAM.About
More news about: Providence Equity Partners L.L.C.
Jul 28, 2026, 11:31 ET Fiocruz e MSD Brasil firmam Memorando de Entendimentos para ampliar acesso à inovação na prevenção do HIV
(Fiocruz) e a MSD Brasil assinaram, em 28 de julho, um Memorando de Entendimentos que prevê a avaliação de uma parceria relacionada ao alimatravir (MK-8527), medicamento em estudo de ação prolongada para Profilaxia Pré-Exposição (PrEP) ao HIV, atualmente em desenvolvimento clínico pela MSD.
More news about: MSD Brasil
Jul 21, 2026, 06:00 ET Phanes Therapeutics Announces Expansion of Clinical Trial Collaboration and Supply Agreement with Merck to Evaluate Spevatamig in Combination with KEYTRUDA® (Pembrolizumab) and Chemotherapy for Treatment of Biliary Tract Cancer
biotech company focused on innovative drug discovery and development in oncology, has expanded their clinical trial collaboration with Merck (known as MSD outside of the US and Canada) to study spevatamig in combination with Merck's anti-PD-1 therapy, KEYTRUDA® (pembrolizumab), and chemotherapy
More news about: Phanes Therapeutics, Inc.
Jul 17, 2026, 15:45 ET When to Schedule an Orthodontic Visit for Children Covered in HelloNation, Featuring Expert Orthodontist Dr. Michelle Mathieson, DMD, MSD
multimedia:https://www.prnewswire.com/news-releases/when-to-schedule-an-orthodontic-visit-for-children-covered-in-hellonation-featuring-expert-orthodontist-dr-michelle-mathieson-dmd-msd-302828798.htmlSOURCE
More news about: HelloNation